In melanoma tumors, the tumor inflammatory infiltrate (CD45+ cells) corresponded to 1.6 ± 0.3% of the total cells and there was no difference in the percentage of CD45+ cells between the two groups of animals (WT versus PAFR KO; Figure 2(a)). This evidence concerns the gene PTPRC and neoplasm.